ATE197994T1 - Verfahren zur bestimmung vom rheumatoiden faktor und kit dazu - Google Patents

Verfahren zur bestimmung vom rheumatoiden faktor und kit dazu

Info

Publication number
ATE197994T1
ATE197994T1 AT94115865T AT94115865T ATE197994T1 AT E197994 T1 ATE197994 T1 AT E197994T1 AT 94115865 T AT94115865 T AT 94115865T AT 94115865 T AT94115865 T AT 94115865T AT E197994 T1 ATE197994 T1 AT E197994T1
Authority
AT
Austria
Prior art keywords
reactant
rheumatoid factor
kit
substance
glycoconjugate
Prior art date
Application number
AT94115865T
Other languages
English (en)
Inventor
Yuji Yamada
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE197994T1 publication Critical patent/ATE197994T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT94115865T 1993-11-19 1994-10-07 Verfahren zur bestimmung vom rheumatoiden faktor und kit dazu ATE197994T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29053793 1993-11-19

Publications (1)

Publication Number Publication Date
ATE197994T1 true ATE197994T1 (de) 2000-12-15

Family

ID=17757313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94115865T ATE197994T1 (de) 1993-11-19 1994-10-07 Verfahren zur bestimmung vom rheumatoiden faktor und kit dazu

Country Status (5)

Country Link
EP (1) EP0662611B1 (de)
KR (1) KR950014137A (de)
AT (1) ATE197994T1 (de)
CA (1) CA2133772A1 (de)
DE (1) DE69426383T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08220099A (ja) * 1995-02-10 1996-08-30 Morinaga Milk Ind Co Ltd 物質の検出試薬及び慢性関節リウマチの検知法
SE9602545L (sv) 1996-06-25 1997-12-26 Michael Mecklenburg Metod för att diskriminera komplexa biologiska prover
DE10249608A1 (de) * 2002-10-18 2004-05-06 Gkss-Forschungszentrum Geesthacht Gmbh Vorrichtung und Verfahren zur Strukturanalyse und Detektion von komplexen Glykostrukturen
EP2037274A1 (de) 2007-09-11 2009-03-18 GALAB Technologies GmbH Lektinbasierter Glykan-Assay
SG11201607484RA (en) 2014-03-13 2016-10-28 Univ Basel Carbohydrate ligands that bind to igm antibodies against myelin-associated glycoprotein
CA2996073A1 (en) 2015-09-16 2017-03-23 Universitat Basel Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63308561A (ja) * 1987-06-10 1988-12-15 Naoyuki Taniguchi 抗原の測定法
GB8726271D0 (en) * 1987-11-10 1987-12-16 Univ London Protein glycosylation assay
CA2016125A1 (en) * 1989-05-19 1990-11-19 Eisai Co., Ltd. Diagnostic drug for rheumatoid arthritis
JP2726500B2 (ja) * 1989-07-14 1998-03-11 学校法人藤田学園 アガラクトシルＩｇＧおよび診断薬

Also Published As

Publication number Publication date
EP0662611A2 (de) 1995-07-12
DE69426383T2 (de) 2001-09-27
DE69426383D1 (de) 2001-01-11
EP0662611A3 (de) 1996-08-21
EP0662611B1 (de) 2000-12-06
KR950014137A (ko) 1995-06-15
CA2133772A1 (en) 1995-05-20

Similar Documents

Publication Publication Date Title
ZA882998B (en) Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans
DK0412486T3 (da) Antistoffer mod TNF-bindingsprotein I og F(ab)-fragmenter
ATE221202T1 (de) Bestimmungsverfahren mit oligomerisierten rezeptoren
NO976122L (no) AntiFasligandantistoffer og analysefremgangsmåte hvor disse anvendes
FI893428A7 (fi) TNF-a:n in vitro ja in vivo toksisten ominaisuuksien eliminointi monoklonaalisilla vasta-aineilla ja niistä johdetuilla fragmenteilla
AU629886B2 (en) Diagnostic test using chimeric antibodies
EP0383313A3 (de) Reagenz für Immuntestverfahren und Kit dieses enhaltend
ATE197994T1 (de) Verfahren zur bestimmung vom rheumatoiden faktor und kit dazu
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
EP1059533A4 (de) Methode zum immunologischen nachweis des anti-hm1.24 antikörpers
AU8944291A (en) Immunoassay for the determination of anti-hiv antibodies in human samples
ES2115750T3 (es) Ensayo de captura de proteinas de union.
ATE283490T1 (de) Cobalamintest
ATE180894T1 (de) Verwendung von polyklonalen humanen anti-htg- autoantikörpern als reagenz für die klinische diagnostik von schilddrüsen-autoimmunerkrankungen sowie reagenziensatz für eine bestimmung von anti-htg-autoantikörpern in patientenseren
WO1998029726A3 (en) Method of detecting and determining the concentration of total troponin i in a biological sample
DK414386D0 (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
EP0250119A3 (de) Atherosclerotischer anti-idiotypischer Antikörper, Immunotest und Reagenzien
FI882019L (fi) Monoklonaalisia vasta-aineita intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) selektiivistä, immunologista määritystä varten kehonnesteistä
WO1987007302A3 (en) MONOCLONAL ANTIBODIES TO HUMAN LYMPHOCYTE IgE RECEPTORS, HYBRIDOMAS PRODUCING SUCH ANTIBODIES, AND KITS FOR USING SUCH ANTIBODIES
NO873154D0 (no) Spesifikke monoklonale antistoffer mot overflatereseptor for ige og hybridcellelinjer som produserer disse antistoffer og anvendelse derav.
AU2868489A (en) Assays for incipient diabetes, monoclonal antibodies used therein and kits for use therefor
AU8008487A (en) A method for determining the presence of substances of diagnostic relevance, in particular antibodies or antigens, by the ELISA method with photometric evaluation
IT8906607A0 (it) Test immunoenzimatico per la ricerca e determinazione degli anticorpi antilattoglobulina bovina nel siero
EP0248630A3 (de) Immuntest für atherosklerotisches Plaque-Antigen
IT8906606A0 (it) Test immunoenzimatico per la ricerca e determinazione degli anticorpi anticaseina bovina nel siero

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee